Attitudinal Correlates of HPV Vaccination in College Women

Abstract

This study examined associations between general attitudes toward seeking medical care, attitudes about vaccines/fear of shots, and human papillomavirus (HPV) vaccine uptake and intentions in college women. Hypothesized associations were framed by the Theory of Planned Behavior (TPB). Participants (N = 330, mean age = 18.9 years, 75% White) completed a one-time survey. The majority (61%; n = 201) had received ≥1 HPV vaccine dose. Hierarchical logistic regression examined relationships between attitudes and vaccine uptake. Pearson correlation coefficients and Kruskal-Wallis tests examined associations between attitudes and vaccine intentions. Results were partially consistent with the TPB. In the final model, perceived benefits, but not fear of shots, were associated with vaccine uptake. Among the unvaccinated, perceived benefits, but not fear of shots, were associated with vaccine intentions. Provider recommendation was the strongest predictor of vaccine uptake. Findings suggest interventions incorporating discussion of perceived benefits and provider recommendation may improve HPV vaccine receipt among college women.

Keywords

health behavior HPV vaccine human papillomavirus vaccination theory of planned behavior cancer prevention

Get full access to this article

View all access options for this article.

References

Affiliated Service Providers of Indiana, Inc. (2011). Indiana state rural health plan. https://www.in.gov/isdh/files/IndianaStateRuralHealthPlan2011final.pdf

Agarwal

(2014). A/H1N1 vaccine intentions in college students: An application of the theory of planned behavior. Journal of American College Health, 62(6), 416–424. https://doi.org/10.1080/07448481.2014.917650

Ajzen

(1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50(2), 179–211. https://doi.org/10.1016/0749-5978(91)90020-t

Barnard

George

Perryman

M. L.

Wolff

L. A.

(2017). Human papillomavirus (HPV) vaccine knowledge, attitudes, and uptake in college students: Implications from the precaution adoption process model. PLoS One, 12(8), e0182266. https://doi.org/10.1371/journal.pone.0182266

Bednarczyk

R. A.

Chu

S. L.

Sickler

Shaw

Nadeau

J. A.

McNutt

L.-A.

(2015). Low uptake of influenza vaccine among university students: Evaluating predictors beyond cost and safety concerns. Vaccine, 33(14), 1659–1663. https://doi.org/10.1016/j.vaccine.2015.02.033

Brewer

N. T.

Hall

M. E.

Malo

T. L.

Gilkey

M. B.

Quinn

Lathren

(2017). Announcements versus conversations to improve HPV vaccination coverage: A randomized trial. Pediatrics, 139, e20161764. https://doi.org/10.1542/peds.2016-1764

Britt

R. K.

Englebert

A. M.

(2018). Behavioral determinants for vaccine acceptability among rurally located college students. Health Psychology and Behavioral Medicine, 6(1), 262–276. https://doi.org/10.1080/21642850.2018.1505519

Brotherton

J. M. L.

Wheeler

Clifford

G. M.

Elfström

Saville

Kaldor

Machalek

D. A.

(2021). Surveillance systems for monitoring cervical cancer elimination efforts: Focus on HPV infection, cervical dysplasia, cervical screening and treatment. Preventive Medicine, 144, 106293. https://doi.org/10.1016/j.ypmed.2020.106293

Bynum

S. A.

Brandt

H. M.

Annang

Friedman

D. B.

Tanner

Sharpe

P. A.

(2012). Do health beliefs, health care system distrust, and racial pride influence HPV vaccine acceptability among African American college females? Journal of Health Psychology, 17(2), 217–226. https://doi.org/10.1177/1359105311412833

10.

Catalano

H. P.

Knowlden

A. P.

Birch

D. A.

Leeper

J. D.

Paschal

A. M.

Usdan

S. L.

(2017). Using the theory of planned behavior to predict HPV vaccination intentions of college men. Journal of American College Health, 65(3), 197–207. https://doi.org/10.1080/07448481.2016.1269771

11.

Catalano

H. P.

Richards

Hawkins

K. H.

(2017). Theory of planned behavior-based correlates of HPV vaccination intentions and series completion among university students in the Southeastern United States. Health Education, 49(2), 35–44.

12.

Centers for Disease Control and Prevention. (2008). 2008 National immunization survey-teen hard copy questionnaire. Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/nis/data_files_teen.htm

13.

Centers for Disease Control and Prevention. (2014). Genital HPV infection—CDC fact sheet. Retrieved April 13, 2021, from http://www.cdc.gov/std/HPV/STDFact-HPV.htm

14.

Centers for Disease Control and Prevention. (2018). Cancer statistics at a glance. Retrieved June 30, 2021, from https://gis.cdc.gov/Cancer/USCS/#/AtAGlance/

15.

Centers for Disease Control and Prevention. (2019). HPV-associated cancer statistics. Retrieved October 9, 2019, from https://www.cdc.gov/cancer/hpv/statistics/

16.

Centers for Disease Control and Prevention. (2010). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 59(20), 630–632.

17.

Elam-Evans

L. D.

Yankey

Singleton

J. A.

Sterrett

Markowitz

L. E.

Williams

C. L.

Fredua

McNamara

Stokley

(2020). National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years – United States, 2019. Morbidity and Mortality Weekly Report, 69(33), 1109–1116.

18.

Fischer

E. H.

Dornelas

E. A.

DiLorenzo

T. A.

(2013). Attitudes toward seeking medical care: Development and standardization of a comprehensive scale. Journal of Applied Social Psychology, 43, E115–E123. https://doi.org/10.1111/jasp.12043

19.

Gerend

M. A.

Shepherd

J. E.

(2012). Predicting human papillomavirus vaccine uptake in young adult women: Comparing the health belief model and theory of planned behavior. Annals of Behavioral Medicine, 44(2), 171–180. https://doi.org/10.1007/s12160-012-9366-5

20.

Gilkey

M. B.

Calo

W. A.

Moss

J. L.

Shah

P. D.

Marciniak

M. W.

Brewer

N. T.

(2016). Provider communication and HPV vaccination: The impact of recommendation quality. Vaccine, 34(9), 1187–1192. https://doi.org/10.1016/j.vaccine.2016.01.023

21.

Hamborsky

Kroger

Wolfe

(2015). Epidemiology and prevention of vaccine-preventable diseases (13th ed.). US Department of Health & Human Services; Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/hpv.pdf

22.

Hariri

Unger

E. R.

Sternberg

Dunne

E. F.

Swan

Patel

Markowitz

L. E.

(2011). Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006. The Journal of Infectious Diseases, 204(4), 566–573. https://doi.org/10.1093/infdis/jir341

23.

Hirth

J. M.

Batuuka

D. N.

Gross

T. T.

Cofie

Berenson

A. B.

(2018). Human papillomavirus vaccine motivators and barriers among community college students: Considerations for development of a successful vaccination program. Vaccine, 36(8), 1032–1037. https://doi.org/10.1016/j.vaccine.2018.01.037

24.

Hodin

Garau

Kalache

(2013). A life-course approach to vaccination can drive healthy aging. Health affairs blog.

25.

Hosmer

D. W.

Jr Lemeshow

Sturdivant

R. X.

(2013). Applied logistic regression (Vol. 398). John Wiley & Sons.

26.

Indiana State Department of Health. (2014). Behavioral risk factor surveillance system, Indiana statewide survey data, 2014. Retrieved December 30, 2019, from https://www.in.gov/isdh/reports/brfss/2014/M11.01.htm

27.

Kasting

M. L.

Giuliano

A. R.

Christy

S. M.

Rouse

C. E.

Robertson

S. E.

Thompson

E. L.

(2020). Human Papillomavirus vaccination prevalence among adults aged 19-45 years: An analysis of the 2017 National Health interview survey. American Journal of Preventive Medicine, 59(6), 837–849. https://doi.org/10.1016/j.amepre.2020.05.031

28.

Landowska

Waller

Bedford

Rockliffe

Forster

A. S.

(2017). Influences on university students’ intention to receive recommended vaccines: A cross-sectional survey. BMJ Open, 7(7), e016544. https://doi.org/10.1136/bmjopen-2017-016544

29.

Larson

H. J.

Clarke

R. M.

Jarrett

Eckersberger

Levine

Schulz

W. S.

Paterson

(2018). Measuring trust in vaccination: A systematic review. Human Vaccines & Immunotherapeutics, 14(7), 1599–1609. https://doi.org/10.1080/21645515.2018.1459252

30.

Lewis

R. M.

Markowitz

L. E.

Gargano

J. W.

Steinau

Unger

E. R.

(2018). Prevalence of genital human Papillomavirus among sexually experienced males and females aged 14-59 years, United States, 2013-2014. The Journal of Infectious Diseases, 217(6), 869–877. https://doi.org/10.1093/infdis/jix655

31.

Liau

Stupiansky

N. W.

Rosenthal

S. L.

Zimet

G. D.

(2012). Health beliefs and vaccine costs regarding human papillomavirus (HPV) vaccination among a U.S. national sample of adult women. Preventive Medicine, 54(3–4), 277–279. https://doi.org/10.1016/j.ypmed.2012.02.002

32.

McLenon

Rogers

M. A. M.

(2019). The fear of needles: A systematic review and meta-analysis. Journal of Advanced Nursing, 75(1), 30–42. https://doi.org/10.1111/jan.13818

33.

Meites

Kempe

Markowitz

L. E.

(2016). Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on immunization practices. MMWR Morbidity and Mortality Weekly Report, 65(49), 1405–1408. https://doi.org/10.15585/mmwr.mm6549a5

34.

Meites

Szilagyi

P. G.

Chesson

H. W.

Unger

E. R.

Romero

J. R.

Markowitz

L. E.

(2019). Human papillomavirus vaccination for adults: Updated recommendations of the Advisory Committee on immunization practices. MMWR Morbidity and Mortality Weekly Report, 68(32), 698–702. https://doi.org/10.15585/mmwr.mm6832a3

35.

National Cancer Institute. (2014). Health information national trends survey (HINTS). http://hints.cancer.gov/

36.

Nowak

G. J.

Shen

A. K.

Schwartz

J. L.

(2017). Using campaigns to improve perceptions of the value of adult vaccination in the United States: Health communication considerations and insights. Vaccine, 35(42), 5543–5550. https://doi.org/10.1016/j.vaccine.2017.08.064

37.

Oliver

S. E.

Unger

E. R.

Lewis

McDaniel

Gargano

J. W.

Steinau

Markowitz

L. E.

(2017). Prevalence of human Papillomavirus among females after vaccine introduction-National Health and Nutrition examination survey, United States, 2003-2014. The Journal of Infectious Diseases, 216(5), 594–603. https://doi.org/10.1093/infdis/jix244

38.

Patel

D. A.

Zochowski

Peterman

Dempsey

A. F.

Ernst

Dalton

V. K.

(2012). Human papillomavirus vaccine intent and uptake among female college students. Journal of American College Health, 60(2), 151–161. https://doi.org/10.1080/07448481.2011.580028

39.

Rolnick

S. J.

Parker

E. D.

Nordin

J. D.

Hedblom

B. D.

Wei

Kerby

Jackson

J. M.

Crain

A. L.

Euler

(2013). Self-report compared to electronic medical record across eight adult vaccines: Do results vary by demographic factors? Vaccine, 31(37), 3928–3935.

40.

Ryan

K. A.

Filipp

S. L.

Gurka

M. J.

Zirulnik

Thompson

L. A.

(2019). Understanding influenza vaccine perspectives and hesitancy in university students to promote increased vaccine uptake. Heliyon, 5(10), e02604. https://doi.org/10.1016/j.heliyon.2019.e02604

41.

Senkomago

Henley

S. J.

Thomas

C. C.

Mix

J. M.

Markowitz

L. E.

Saraiya

(2019). Human papillomavirus-attributable cancers – United States, 2012-2016. Morbidity and Mortality Weekly Report, 68(33), 724–728.

42.

Short

M. B.

Rosenthal

S. L.

Sturm

Black

Loza

Breitkopf

Zimet

G. D.

(2010). Adult women’s attitudes toward the HPV vaccine. Journal of Womens Health, 19(7), 1305–1311. https://doi.org/10.1089/jwh.2009.1471

43.

Stout

M. E.

Christy

S. M.

Winger

J. G.

Vadaparampil

S. T.

Mosher

C. E.

(2020). Self-efficacy and HPV vaccine attitudes mediate the relationship between social norms and intentions to receive the HPV vaccine among college students. Journal of Community Health, 45(6), 1187–1195. https://doi.org/10.1007/s10900-020-00837-5

44.

Sturm

Donahue

Kasting

Kulkarni

Brewer

N. T.

Zimet

G. D.

(2017). Pediatrician-parent conversations about human papillomavirus vaccination: An analysis of audio recordings. Journal of Adolescent Health, 61(2), 246–251. https://doi.org/10.1016/j.jadohealth.2017.02.006

45.

Thomas

Higgins

Ding

Widdice

L. E.

Chandler

Kahn

J. A.

(2016). Factors associated with HPV vaccine initiation, vaccine completion, and accuracy of self-reported vaccination status among 13- to 26-year-old men. American Journal of Men’s Health, 12(4), 819–827. https://doi.org/10.1177/1557988316645155

46.

Thomas

T. L.

Strickland

Diclemente

Higgins

(2013). An opportunity for cancer prevention during preadolescence and adolescence: Stopping human papillomavirus (HPV)-related cancer through HPV vaccination. Journal of Adolescent Health, 52(Suppl. 5), S60–S68. https://doi.org/10.1016/j.jadohealth.2012.08.011

47.

U.S. Food and Drug Administration. (2006). Approved products- Gardasil. Silver Spring. https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094042.htm

48.

U.S. Food and Drug Administration. (2015). FDA licensure of 9-valent human papillomavirus vaccine to include males aged 16–26 years—December 14, 2015. cdc.gov/hpv/downloads/9vhpv-fda.pdf

49.

Walker

T. Y.

Elam-Evans

L. D.

Williams

C. L.

Fredua

Yankey

Markowitz

L. E.

Stokley

(2020). Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13-17 by metropolitan statistical area (MSA) status, National Immunization survey – teen, 2013 - 2017. Human Vaccines & Immunotherapeutics, 16(3), 554–561. https://doi.org/10.1080/21645515.2019.1671765

50.

Winger

J. G.

Christy

S. M.

Mosher

C. E.

(2016). Associations of health behaviors with human papillomavirus vaccine uptake, completion, and intentions among female undergraduate students. Journal of Health Psychology, 21(9), 1949–1955. https://doi.org/10.1177/1359105315569093

51.

Ylitalo

K. R.

Lee

Mehta

N. K.

(2013). Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization survey. American Journal of Public Health, 103(1), 164–169. https://doi.org/10.2105/ajph.2011.300600